SlideShare a Scribd company logo
Case
Presentation
• B/o Sabiya Banu,32 wks,1.7kg,admitted on 2HOL
with provisional diagnosis of MPT/LBW/Moderate
RDS.
• H/o PPROM>72 hours,no antenatal steroids.
• CPAP started at 2 HOL,recieved late rescue
surfactant at 4HOL ,INSURE .
• Removed from CPAP at 48 HOL.
• Initial septic screen was negative.
• Baby on 2nd line Ab as per protocol.
• Baby started with feeds 3ml/3hrly RTF of EBM on D3 of life.
• Feeds gradually increased twice daily
increment(30ml/kg/day)
• On D7 of life baby on 23ml RTF,developed abdominal
distension,residual feeds.AG-27cm.
• Abdomen –Soft,mild distension,non tender,Bowel sounds –
heard.No abdomen wall edema/erythema.
• Investigations-TLC-10,590/cumm,
Plt-12,000/cumm.CRP-62.5mg/dl. Serum Na-124mEq/dl.
• Stool occult blood-positive
• Diagnosis of NEC stage 1A was made .
• Baby kept NPO and Ab’s changed to Meropenem &
ofloxacin
• In view of broad spectrum Ab’s and other risk factors
Flucanozole was added.
• Surgical consultation –advised for medical line of
management.
• After 48hrs of bowel rest,Repeat invetsigations requested
showed-TLC-7870/cumm,PLT-40000/cumm and CRP of
94.1mg/L.
• In view of persistent distension and RTA baby was kept NPO
for 5days.
• Baby was restarted on feeds after 5 days of bowel
rest.(D=9)
• Baby started with 3ml RTF/3hrly and gradually increased
with once daily increment.
• After 3 days of feed on 10ml/EBM 3 hrly,baby had repeat
bout of feed intolerance.(D=12 )
• Repeat counts D12-Hb-11.3Gm%,TLC-10,720 and
platelet -35,000/cumm. CRP-53.2mg/L.
• USG abdomen D15-Minimal turbid ascites,small bowel
edema,no pneumobilia.
• Diagnosis was revised to NEC stage 2B.
• Baby kept NBM and continued with same
antibiotics.
• On D19 baby noticed to have significant
tachycardia 190bpm,bounding periphreal pulses
and PSM.Screening echo showed PDA 4mm with L
to R shunt.(RFT-WNL,Plt-75,000/cumm)
• Received Oral Ibubrofen for 3days.
• Baby restarted on feeds after 7 days of bowel rest
D21 of life RTF EBM 3ml/3hrly.
MODERATE PT(32WK)/LBW/MODERATE
RDS/STAGE 2B NEC/HS PDA 4MM L TO
R SHUNT.
NEC
• Most common GI emergencies in the newborn
infant.
• Defined as:
Transmural coagulative necrosis of the
intestinal mucosa,with invasion of enteric gas
forming organisms, and dissection of gas into
the muscularis and portal venous system .
Epidemology:
• 1 -3 /1000 live births and 1 -7.7 % of admissions to
NICUs .
• Rates were inversely related to BW
401 to 750 g – 11.5%
751 to 1000 g – 9 %
1001 to 1250 g – 6 %
1251 to 1500 g – 4 %
• Mortality rates range from 15- 30% and are inversely
related to GA and BW.
• Approximately 13 % of cases occur in term,have a pre
existing illness- IUGR,congenital heart disease ,
respiratory distress , sepsis , birth asphyxia , and
polycythemia .
Pathology:
• The terminal ileum and colon are MC involved,
entire GI tract is affected in severe cases.
• On gross examination- the bowel distended and
hemorrhagic. Subserosal collections of
gas,gangrenous necrosis and perforation may be
present.
• Histologic findings in NEC -mucosal edema,
hemorrhage, and transmural coagulative
necrosis.
-secondary bacterial infiltration, and collections of
gas.
Gross Microscopy
Pathogenesis:Factors implicated in NEC
• Prematurity
• Enteral nutrition
• Circulatory instability of the intestinal tract.
• Microbial bowel overgrowth
• Medications that cause intestinal mucosal injury or enhance
microbial overgrowth-Antibiotics,H2 blockers.
• Maternal choriamniotis.
• IUGR with doppler changes.
• Maternal smoking,coccaine use.
• Polycythemia
• Anemia ,PRBC transfusion.
• Umbilical cathetristaion
• Oral indomethacin
Pathogeneis:
Prematurity:
• Immature mucosal barrier with increased
permeability
• Immature local host defenses.
• Immature bowel motility and function.
Enteral nutrition
• More than 90 percent of infants who develop NEC have
received milk feeding
• Incompletely digested carbohydrates and lipids in the
intestine of preterm infants cause mucosal injury .
• Human milk, protective :PAF acetylhydrolase, S IgA, IL-
10, IL-11, EGF , nucleotides, glutamine, and
antioxidants such as vit E, carotene, and glutathione.
Anemia & RBC transfusion:
• Multicenter observational’ cohort study
reported that severe anemia and not RBC
transfusion was associated with NEC.
• Clinically-significant anemia is associated with
an increased risk for NEC, and that RBC
transfusion is only a surrogate marker for
anemia
‘Patel RM, Knezevic A, Shenvi N, et al. Association of Red Blood Cell Transfusion, Anemia, and
Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016; 315:889
Medications
• Hyperosmolar medications and formulas can
cause mucosal injury and may result in NEC-
oral theophylline, multivitamins,
or phenobarbitone.
• Cimetidine, ranitidine, and famotidine, are
associated with higher rates of NEC.
• Antibiotic administration greater than five
days duration is associated with an increased
risk of NEC or death
Clinical Presentation:
• Majority of premature infants who develop
NEC are healthy, feeding well, and growing
babies.
• Onset of symptoms varies and is inversely
related to gestational age
GA< 26 weeks-23 days,
GA >31 weeks- 11 days.
• Indian data peak age –end of 1stwk to 2nd
week
Systemic Signs
• Apnea,Bradycardia
• Respiratory distress
• Lethargy
• Poor feeding
• Temperature instability.
• Hypotension
• Bleeding diathesis with
consumption coagulopathy.
Abdominal Signs
• Gastric retention
• Abdominal Distension
• Abdominal redness &
tenderness
• Vomiting.
• Diarrhea.
• Rectal bleeding
(hematochezia)
• Bilious drainage from
enteral feeding tubes
Modified Bells staging for NEC:
• Bell staging criteria (Walsh & Kleigman)
provide a uniform definition of NEC based
upon the severity of systemic, intestinal, and
radiographic findings.
1. Stage I/suspected NEC
2. Stage II/proven NEC
3. Stage III/advanced NEC
Bells Staging Criteria
Investigations:
Abdomen X ray
• Abnormal gas pattern with dilated loops of bowel -ileus, early stages
of NEC.
• Bowel wall edema
• Pneumatosis intestinalis, the hallmark of NEC, appears as bubbles of
gas in the small bowel wall, stages II and III NEC .
• Gasless abdomen indicating ascites.
• Pneumoperitoneum bowel perforation occurs , IIIB NEC.
-"football" sign on a supine radiograph,large hypolucent area in the
central abdomen with markings from the falciform ligament.
• Sentinel loops, a loop of bowel that remains in fixed position, is
suggestive of necrotic bowel and/or perforation in the absence of
pneumatosis intestinalis.
In EPT, treatment -clinical suspicion as confirmatory
radiographic findings may not be present
USG abdomen:
• USG more sensitive method to detect
intramural air and portal venous gas .
• USG can detect intermittent gas bubbles in
liver parenchyma and the portal venous
system that are not detected by radiographs
• Color Doppler USG more sensitive than
abdominal radiography in detecting bowel
necrosis and alterations in bowel wall
perfusion
Blood and serum studies:
• WBC count <1500/cumm –poor prognostic factor
• Thrombocytopenia, persistent metabolic acidosis, and severe
refractory hyponatremia triad of signs and help to confirm the
diagnosis.
• Serial measurements of CRP - diagnosis and assessment of
response to therapy of severe NEC.
• Blood cultures are positive in ˜40% of cases
Analysis of stool:
• Grossly bloody stools may be an indication of NEC, routine
testing of stool for occult blood has no value .
• 60% of infants will have Hemoccult-positive stools at any
given time during hospitalization without any evidence for
NEC
D/D’s
1. Sepsis with Ileus
2. Infectious enteritis
3. Spontaneous intestinal perforation of the
newborn
4. Intestinal obstruction –enterocolitis in
Hirschsprung disease, ileal atresia, volvulus,
meconium ileus, and intussusception.
5. Anal fissures
6. Neonatal appendicitis
7. Cow's milk protein allergy
Management:
• Medical management
-Supportive care
-Antibiotics
-Radilogical and lab monitoring
• Surgical management
-Primary peritonael drainage
-Laprotomy
Supportive Care:
• Bowel rest with gastrointestinal decompression
with intermittent nasogastric suction.
• Total parenteral nutrition
• Fluid replacement to correct third space losses
• Support of both the cardiovascular( inotropes)
and respiratory systems (O2 & Ventilation as
needed).
• Correction of hematologic (DIC) and metabolic
abnormalities (metabolic acidosis).
Antibiotics:
• After obtaining appropriate specimens for
culture, broad spectrum antibiotic treatment
should be initiated for suspected or proven
NEC.
• Regimens should provide coverage for
pathogens that cause late-onset bacteremia.
• Anaerobic coverage considered-peritonitis or
pneumoperitoneum, suggesting intestinal
perforation.
• Lack of consensus, and the choice of
antibiotic regimen varies among NICU
1. Ampicillin, gentamicin ,and metronidazole
2. Ampicillin, gentamicin, and clindamycin
3. Ampicillin, cefotaxime, and metronidazole
4. Piperacillin.tazobactam and gentamicin
5. Vancomycin, piperacillin-tazobactam,
and gentamicin.
6. Meropenem
Surgical management:
Indications
• Perforation on abdominal X
ray(pneumoperitoneum)
• Positvie test on paracentesis(stool ,organism)
• Failure of medical management.
• Single fixed bowel loop on radiograph
• Abdominal wall erythema.
• Palpable mass
• Ideally surgery performed after intestinal necrosis
but before perfoartion and peritonitis develop.
• Surgical procedures- exploratory laparotomy with
resection of the affected intestinal region, or
primary peritoneal drainage (PPD).
• PPD may be the preferred initial surgical
procedure in extremely low birth weight (ELBW)
infants and unstable premature infants.
Complications:
Early:
• Infectious complications – Sepsis, meningitis,
peritonitis, and abscess formation
• Disseminated intravascular coagulation- intestinal or
extraintestinal bleeding
• Respiratory and cardiovascular complications –
Hypotension, shock, and respiratory failure
• Metabolic complications – Hypoglycemia and
metabolic acidosis
Late:
• Stricture formation(9-36%)
• Short bowel syndrome.(9% surgical operated cases)
Mortality:
71,808 premature infants who were born between January 2005 and
December 2006 -Vermont Oxford Network
Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J
Pediatr Surg 2009; 44:1072
 BW 501 to 750 g – 42 %
 BW 751 to 1000 g – 29 %
 BW 1001 to 1250 g – 21 %
 BW 1251 to 1500 g – 16 %
• Mortality rate is higher in infants with more severe disease requiring
surgical intervention(30.8 versus 6.8 percent).
• Radiographic evidence of portal venous air, an increase in feeding volume
that was greater than 20 mL/kg per day, and an increase in the
concentration of HMF within 48 hours of developing NEC .
• Hematocrit < 22 % ,I:T ratio > 0.5, and total lymphocyte count
below 4000/microlt
Long term outcome:
• Approximately one-half of survivors have no long-term sequel.
• 10% infants will have late gastrointestinal morbidity-
persistent loose stools or frequent bowel movements
• Infants with NEC were at increased risk for cerebral palsy, and
cognitive and severe visual impairment.
• Patients who were surgically treated had poorer
neurodevelopmental outcome than those treated medically.
• ELBW infants who required surgical care were more likely to
have significant growth delay and poorer developmental
outcome at 18 to 22 months.
Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight
infants after necrotizing enterocolitis. Pediatrics 2005; 115:696.
Prevention of NEC:
• Antenatal corticosteroids reduced the risk for NEC
approximately by half.
• Human milk compared with formula is the most important strategy
associated with a lower risk of NEC( 2.8 times risk in formula fed)
• TIMING AND ADVANCEMENT OF FEEDING
 The optimal timing of initiation of minimal enteral (trophic) feeding
remains uncertain and its association with NEC is lacking.
 Advancement of enteral feed volumes at daily increments of 30 to
40 mL/kg compared to lower volumes of 15 to 24 mL/kg did not
increase the risk of NEC or death in VLBW infants (BW <1500 g)
Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very
low birth weight infants. Cochrane Database Syst Rev 2015; :CD001241
Prevention of NEC:
• Routine use of probiotic –not recomended, the lack of an established
regimen of optimal strain and dosing, and the absence of quality
control regulation to ensure consistency and safety of product.
• Oral immunoglobulins may reduce NEC by inhibiting the release of
proinflammatory cytokines ,meta analysis administration of oral IgG
or IgG/IgA combination did not reduce the incidence .
• Lactoferrin,Arginine,Glutamine ,HMO-proven to be beneficaial in
some studies but not routinely recommended.
Prevention of NEC:
• Avoidance of histamine 2 blockers:Immunity provided
by gastric acid may be important in preventing the
cascade of infectious and inflammatory events.
• Avoidance of prolonged empirical antibiotic use :use of
prolonged initial empiric antibiotic (≥5 days duration)
started in the first three days of life was associated
with an increased risk of NEC or death.
• Unproven as measures to prevent NEC:use of feeding
protocols, judicious advancement of feeding, avoidance
of hypertonic formulas and contrast agents, and
prompt treatment of polycythemia.
NEC in newborn

More Related Content

What's hot

Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
Dr Padmesh Vadakepat
 
Approach to Vomiting in children
Approach to Vomiting in children Approach to Vomiting in children
Approach to Vomiting in children
Kannan Chinnasamy
 
NewBorn Who Fails to Pass Meconium - Final Year Lecture
NewBorn Who Fails to Pass Meconium - Final Year LectureNewBorn Who Fails to Pass Meconium - Final Year Lecture
NewBorn Who Fails to Pass Meconium - Final Year LectureMr Adeel Abbas
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
Brian Shiluli
 
Necrotizing Enterocolitis
Necrotizing EnterocolitisNecrotizing Enterocolitis
Necrotizing Enterocolitis
Raghavendra Babu
 
Neonatal fluid requirements and specials conditions
Neonatal fluid requirements and specials conditionsNeonatal fluid requirements and specials conditions
Neonatal fluid requirements and specials conditions
Rakesh Verma
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
Dr. Maimuna Sayeed
 
Bronchopulmonary Dysplasia
Bronchopulmonary DysplasiaBronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
Dr Anand Singh
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttn
Tarek Kotb
 
Chronic diarrhoea in children
Chronic diarrhoea in childrenChronic diarrhoea in children
Chronic diarrhoea in children
Virendra Hindustani
 
Pneumonia Pediatric
Pneumonia PediatricPneumonia Pediatric
Pneumonia Pediatric
Dr V K Pandey
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
Azad Haleem
 
Diabetic keto acidosis in children ... Dr.Padmesh
Diabetic keto acidosis in children ...  Dr.PadmeshDiabetic keto acidosis in children ...  Dr.Padmesh
Diabetic keto acidosis in children ... Dr.Padmesh
Dr Padmesh Vadakepat
 
Approach to Polyuria in Children... Dr.Padmesh
Approach to Polyuria in Children...  Dr.PadmeshApproach to Polyuria in Children...  Dr.Padmesh
Approach to Polyuria in Children... Dr.Padmesh
Dr Padmesh Vadakepat
 
HIE Birth asphyxia in Neonates
HIE Birth asphyxia in NeonatesHIE Birth asphyxia in Neonates
HIE Birth asphyxia in Neonates
Sujit Shrestha
 
Managment of prolonged jaundice
Managment of prolonged jaundiceManagment of prolonged jaundice
Managment of prolonged jaundice
Mohamed Adan Ahmed (marwan)
 

What's hot (20)

Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
Diagnosis and management of dengue in children (IAP Infectious Diseases Chapter)
 
Approach to Vomiting in children
Approach to Vomiting in children Approach to Vomiting in children
Approach to Vomiting in children
 
Nec
NecNec
Nec
 
NewBorn Who Fails to Pass Meconium - Final Year Lecture
NewBorn Who Fails to Pass Meconium - Final Year LectureNewBorn Who Fails to Pass Meconium - Final Year Lecture
NewBorn Who Fails to Pass Meconium - Final Year Lecture
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
 
Pphn
PphnPphn
Pphn
 
Necrotizing Enterocolitis
Necrotizing EnterocolitisNecrotizing Enterocolitis
Necrotizing Enterocolitis
 
Neonatal fluid requirements and specials conditions
Neonatal fluid requirements and specials conditionsNeonatal fluid requirements and specials conditions
Neonatal fluid requirements and specials conditions
 
Neonatal Cholestasis
Neonatal CholestasisNeonatal Cholestasis
Neonatal Cholestasis
 
Bronchopulmonary Dysplasia
Bronchopulmonary DysplasiaBronchopulmonary Dysplasia
Bronchopulmonary Dysplasia
 
Transient tachypnea of newborn ttn
Transient tachypnea of newborn ttnTransient tachypnea of newborn ttn
Transient tachypnea of newborn ttn
 
Chronic diarrhoea in children
Chronic diarrhoea in childrenChronic diarrhoea in children
Chronic diarrhoea in children
 
Neonatal seizures
Neonatal seizuresNeonatal seizures
Neonatal seizures
 
Pneumonia Pediatric
Pneumonia PediatricPneumonia Pediatric
Pneumonia Pediatric
 
Necrotizing Enterocolitis
Necrotizing EnterocolitisNecrotizing Enterocolitis
Necrotizing Enterocolitis
 
Neonatal jaundice
Neonatal jaundiceNeonatal jaundice
Neonatal jaundice
 
Diabetic keto acidosis in children ... Dr.Padmesh
Diabetic keto acidosis in children ...  Dr.PadmeshDiabetic keto acidosis in children ...  Dr.Padmesh
Diabetic keto acidosis in children ... Dr.Padmesh
 
Approach to Polyuria in Children... Dr.Padmesh
Approach to Polyuria in Children...  Dr.PadmeshApproach to Polyuria in Children...  Dr.Padmesh
Approach to Polyuria in Children... Dr.Padmesh
 
HIE Birth asphyxia in Neonates
HIE Birth asphyxia in NeonatesHIE Birth asphyxia in Neonates
HIE Birth asphyxia in Neonates
 
Managment of prolonged jaundice
Managment of prolonged jaundiceManagment of prolonged jaundice
Managment of prolonged jaundice
 

Similar to NEC in newborn

Nec by Dr Achumie
Nec by Dr AchumieNec by Dr Achumie
Nec by Dr Achumie
Victoria Achumie
 
IEM - A case study
IEM - A case studyIEM - A case study
IEM - A case study
AhmadMenshawy
 
Intestinal obstruction Neonates
 Intestinal obstruction Neonates Intestinal obstruction Neonates
Intestinal obstruction Neonates
Chandan Gowda
 
Neonatal Necrotizing Enterocolitis
Neonatal Necrotizing EnterocolitisNeonatal Necrotizing Enterocolitis
Neonatal Necrotizing Enterocolitis
sumona keya
 
Neonatal Necrotizing Enterocolitis
Neonatal Necrotizing EnterocolitisNeonatal Necrotizing Enterocolitis
Neonatal Necrotizing Enterocolitis
sumona keya
 
Infantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosisInfantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosis
AbdullahIhsaas
 
46_NecEnt (1).pdf
46_NecEnt (1).pdf46_NecEnt (1).pdf
46_NecEnt (1).pdf
YohanesArgo
 
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptxCYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
PrashantKoirala12
 
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptxCYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
PrashantKoirala11
 
CYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptxCYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptx
PrashantKoirala12
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
Leor Arbel
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
Malith Parakrama
 
NICU NEC.pptx
NICU NEC.pptxNICU NEC.pptx
NICU NEC.pptx
Yvonne Nyatundo
 
Necrotizing enterocolitis by phocas
Necrotizing enterocolitis by phocasNecrotizing enterocolitis by phocas
Necrotizing enterocolitis by phocas
PhocasBIMENYIMANA
 
2 diseases of the newborn
2 diseases of the newborn2 diseases of the newborn
2 diseases of the newbornNyl Oineza
 
Infantile hypertrophic pyloric stenosis
Infantile hypertrophic pyloric stenosisInfantile hypertrophic pyloric stenosis
Infantile hypertrophic pyloric stenosisMuki Neurogisty
 
NEC Dr Sam Ojedokun.pptx
NEC Dr Sam Ojedokun.pptxNEC Dr Sam Ojedokun.pptx
NEC Dr Sam Ojedokun.pptx
Samson Ojedokun
 
NEWBORN BABIES (NB)
NEWBORN BABIES (NB)NEWBORN BABIES (NB)
NEWBORN BABIES (NB)
deiaaldeen khudhair
 

Similar to NEC in newborn (20)

Nec by Dr Achumie
Nec by Dr AchumieNec by Dr Achumie
Nec by Dr Achumie
 
IEM - A case study
IEM - A case studyIEM - A case study
IEM - A case study
 
Intestinal obstruction Neonates
 Intestinal obstruction Neonates Intestinal obstruction Neonates
Intestinal obstruction Neonates
 
Neonatal Necrotizing Enterocolitis
Neonatal Necrotizing EnterocolitisNeonatal Necrotizing Enterocolitis
Neonatal Necrotizing Enterocolitis
 
Neonatal Necrotizing Enterocolitis
Neonatal Necrotizing EnterocolitisNeonatal Necrotizing Enterocolitis
Neonatal Necrotizing Enterocolitis
 
Infantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosisInfantile hyperthropic pyloric stenosis
Infantile hyperthropic pyloric stenosis
 
Case ihps
Case ihpsCase ihps
Case ihps
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
 
46_NecEnt (1).pdf
46_NecEnt (1).pdf46_NecEnt (1).pdf
46_NecEnt (1).pdf
 
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptxCYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
 
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptxCYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
 
CYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptxCYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptx
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
 
Necrotizing enterocolitis
Necrotizing enterocolitisNecrotizing enterocolitis
Necrotizing enterocolitis
 
NICU NEC.pptx
NICU NEC.pptxNICU NEC.pptx
NICU NEC.pptx
 
Necrotizing enterocolitis by phocas
Necrotizing enterocolitis by phocasNecrotizing enterocolitis by phocas
Necrotizing enterocolitis by phocas
 
2 diseases of the newborn
2 diseases of the newborn2 diseases of the newborn
2 diseases of the newborn
 
Infantile hypertrophic pyloric stenosis
Infantile hypertrophic pyloric stenosisInfantile hypertrophic pyloric stenosis
Infantile hypertrophic pyloric stenosis
 
NEC Dr Sam Ojedokun.pptx
NEC Dr Sam Ojedokun.pptxNEC Dr Sam Ojedokun.pptx
NEC Dr Sam Ojedokun.pptx
 
NEWBORN BABIES (NB)
NEWBORN BABIES (NB)NEWBORN BABIES (NB)
NEWBORN BABIES (NB)
 

More from Chandan Gowda

Kernicterus/BIND-pathogenesis
Kernicterus/BIND-pathogenesisKernicterus/BIND-pathogenesis
Kernicterus/BIND-pathogenesis
Chandan Gowda
 
Breast feeding support
Breast feeding support Breast feeding support
Breast feeding support
Chandan Gowda
 
NRP 2015 update on MSAF
NRP 2015 update on MSAF NRP 2015 update on MSAF
NRP 2015 update on MSAF
Chandan Gowda
 
Persistent pulmonary hypertension of newborn PPHN
Persistent pulmonary hypertension of newborn PPHNPersistent pulmonary hypertension of newborn PPHN
Persistent pulmonary hypertension of newborn PPHN
Chandan Gowda
 
Neonatal resuscitation 2015 aha guidelines update for cpr
Neonatal resuscitation 2015 aha guidelines update for cprNeonatal resuscitation 2015 aha guidelines update for cpr
Neonatal resuscitation 2015 aha guidelines update for cpr
Chandan Gowda
 
Infective endocarditis-Neonate
 Infective endocarditis-Neonate Infective endocarditis-Neonate
Infective endocarditis-Neonate
Chandan Gowda
 
Cardiac adaptation
Cardiac adaptationCardiac adaptation
Cardiac adaptation
Chandan Gowda
 
Congenital heart block
Congenital heart blockCongenital heart block
Congenital heart block
Chandan Gowda
 
Bronchopulmonary dysplasia
Bronchopulmonary dysplasiaBronchopulmonary dysplasia
Bronchopulmonary dysplasia
Chandan Gowda
 
Oxygen transport
Oxygen  transportOxygen  transport
Oxygen transport
Chandan Gowda
 
Neonatal mechanical ventilation
Neonatal mechanical ventilationNeonatal mechanical ventilation
Neonatal mechanical ventilation
Chandan Gowda
 
Human milk composition jc
Human milk composition jcHuman milk composition jc
Human milk composition jc
Chandan Gowda
 
Neonatal Hypoglycemia
Neonatal HypoglycemiaNeonatal Hypoglycemia
Neonatal Hypoglycemia
Chandan Gowda
 
Hearing screening newborn
Hearing screening  newbornHearing screening  newborn
Hearing screening newborn
Chandan Gowda
 
Approach to neonatal anemia
Approach to neonatal anemiaApproach to neonatal anemia
Approach to neonatal anemia
Chandan Gowda
 
Cpap
CpapCpap
Polycythemia
PolycythemiaPolycythemia
Polycythemia
Chandan Gowda
 
Apparent life threatening event
Apparent life threatening eventApparent life threatening event
Apparent life threatening event
Chandan Gowda
 
Birth asphyxia neurpathology
Birth asphyxia neurpathologyBirth asphyxia neurpathology
Birth asphyxia neurpathology
Chandan Gowda
 

More from Chandan Gowda (19)

Kernicterus/BIND-pathogenesis
Kernicterus/BIND-pathogenesisKernicterus/BIND-pathogenesis
Kernicterus/BIND-pathogenesis
 
Breast feeding support
Breast feeding support Breast feeding support
Breast feeding support
 
NRP 2015 update on MSAF
NRP 2015 update on MSAF NRP 2015 update on MSAF
NRP 2015 update on MSAF
 
Persistent pulmonary hypertension of newborn PPHN
Persistent pulmonary hypertension of newborn PPHNPersistent pulmonary hypertension of newborn PPHN
Persistent pulmonary hypertension of newborn PPHN
 
Neonatal resuscitation 2015 aha guidelines update for cpr
Neonatal resuscitation 2015 aha guidelines update for cprNeonatal resuscitation 2015 aha guidelines update for cpr
Neonatal resuscitation 2015 aha guidelines update for cpr
 
Infective endocarditis-Neonate
 Infective endocarditis-Neonate Infective endocarditis-Neonate
Infective endocarditis-Neonate
 
Cardiac adaptation
Cardiac adaptationCardiac adaptation
Cardiac adaptation
 
Congenital heart block
Congenital heart blockCongenital heart block
Congenital heart block
 
Bronchopulmonary dysplasia
Bronchopulmonary dysplasiaBronchopulmonary dysplasia
Bronchopulmonary dysplasia
 
Oxygen transport
Oxygen  transportOxygen  transport
Oxygen transport
 
Neonatal mechanical ventilation
Neonatal mechanical ventilationNeonatal mechanical ventilation
Neonatal mechanical ventilation
 
Human milk composition jc
Human milk composition jcHuman milk composition jc
Human milk composition jc
 
Neonatal Hypoglycemia
Neonatal HypoglycemiaNeonatal Hypoglycemia
Neonatal Hypoglycemia
 
Hearing screening newborn
Hearing screening  newbornHearing screening  newborn
Hearing screening newborn
 
Approach to neonatal anemia
Approach to neonatal anemiaApproach to neonatal anemia
Approach to neonatal anemia
 
Cpap
CpapCpap
Cpap
 
Polycythemia
PolycythemiaPolycythemia
Polycythemia
 
Apparent life threatening event
Apparent life threatening eventApparent life threatening event
Apparent life threatening event
 
Birth asphyxia neurpathology
Birth asphyxia neurpathologyBirth asphyxia neurpathology
Birth asphyxia neurpathology
 

Recently uploaded

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
Catherine Liao
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
LanceCatedral
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 

Recently uploaded (20)

basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...
 
How to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for DoctorsHow to Give Better Lectures: Some Tips for Doctors
How to Give Better Lectures: Some Tips for Doctors
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 

NEC in newborn

  • 2. • B/o Sabiya Banu,32 wks,1.7kg,admitted on 2HOL with provisional diagnosis of MPT/LBW/Moderate RDS. • H/o PPROM>72 hours,no antenatal steroids. • CPAP started at 2 HOL,recieved late rescue surfactant at 4HOL ,INSURE . • Removed from CPAP at 48 HOL. • Initial septic screen was negative. • Baby on 2nd line Ab as per protocol.
  • 3. • Baby started with feeds 3ml/3hrly RTF of EBM on D3 of life. • Feeds gradually increased twice daily increment(30ml/kg/day) • On D7 of life baby on 23ml RTF,developed abdominal distension,residual feeds.AG-27cm. • Abdomen –Soft,mild distension,non tender,Bowel sounds – heard.No abdomen wall edema/erythema. • Investigations-TLC-10,590/cumm, Plt-12,000/cumm.CRP-62.5mg/dl. Serum Na-124mEq/dl. • Stool occult blood-positive • Diagnosis of NEC stage 1A was made . • Baby kept NPO and Ab’s changed to Meropenem & ofloxacin • In view of broad spectrum Ab’s and other risk factors Flucanozole was added.
  • 4. • Surgical consultation –advised for medical line of management. • After 48hrs of bowel rest,Repeat invetsigations requested showed-TLC-7870/cumm,PLT-40000/cumm and CRP of 94.1mg/L. • In view of persistent distension and RTA baby was kept NPO for 5days. • Baby was restarted on feeds after 5 days of bowel rest.(D=9) • Baby started with 3ml RTF/3hrly and gradually increased with once daily increment. • After 3 days of feed on 10ml/EBM 3 hrly,baby had repeat bout of feed intolerance.(D=12 ) • Repeat counts D12-Hb-11.3Gm%,TLC-10,720 and platelet -35,000/cumm. CRP-53.2mg/L. • USG abdomen D15-Minimal turbid ascites,small bowel edema,no pneumobilia. • Diagnosis was revised to NEC stage 2B.
  • 5. • Baby kept NBM and continued with same antibiotics. • On D19 baby noticed to have significant tachycardia 190bpm,bounding periphreal pulses and PSM.Screening echo showed PDA 4mm with L to R shunt.(RFT-WNL,Plt-75,000/cumm) • Received Oral Ibubrofen for 3days. • Baby restarted on feeds after 7 days of bowel rest D21 of life RTF EBM 3ml/3hrly.
  • 6. MODERATE PT(32WK)/LBW/MODERATE RDS/STAGE 2B NEC/HS PDA 4MM L TO R SHUNT.
  • 7. NEC
  • 8. • Most common GI emergencies in the newborn infant. • Defined as: Transmural coagulative necrosis of the intestinal mucosa,with invasion of enteric gas forming organisms, and dissection of gas into the muscularis and portal venous system .
  • 9. Epidemology: • 1 -3 /1000 live births and 1 -7.7 % of admissions to NICUs . • Rates were inversely related to BW 401 to 750 g – 11.5% 751 to 1000 g – 9 % 1001 to 1250 g – 6 % 1251 to 1500 g – 4 % • Mortality rates range from 15- 30% and are inversely related to GA and BW. • Approximately 13 % of cases occur in term,have a pre existing illness- IUGR,congenital heart disease , respiratory distress , sepsis , birth asphyxia , and polycythemia .
  • 10. Pathology: • The terminal ileum and colon are MC involved, entire GI tract is affected in severe cases. • On gross examination- the bowel distended and hemorrhagic. Subserosal collections of gas,gangrenous necrosis and perforation may be present. • Histologic findings in NEC -mucosal edema, hemorrhage, and transmural coagulative necrosis. -secondary bacterial infiltration, and collections of gas.
  • 12. Pathogenesis:Factors implicated in NEC • Prematurity • Enteral nutrition • Circulatory instability of the intestinal tract. • Microbial bowel overgrowth • Medications that cause intestinal mucosal injury or enhance microbial overgrowth-Antibiotics,H2 blockers. • Maternal choriamniotis. • IUGR with doppler changes. • Maternal smoking,coccaine use. • Polycythemia • Anemia ,PRBC transfusion. • Umbilical cathetristaion • Oral indomethacin
  • 14. Prematurity: • Immature mucosal barrier with increased permeability • Immature local host defenses. • Immature bowel motility and function.
  • 15. Enteral nutrition • More than 90 percent of infants who develop NEC have received milk feeding • Incompletely digested carbohydrates and lipids in the intestine of preterm infants cause mucosal injury . • Human milk, protective :PAF acetylhydrolase, S IgA, IL- 10, IL-11, EGF , nucleotides, glutamine, and antioxidants such as vit E, carotene, and glutathione.
  • 16. Anemia & RBC transfusion: • Multicenter observational’ cohort study reported that severe anemia and not RBC transfusion was associated with NEC. • Clinically-significant anemia is associated with an increased risk for NEC, and that RBC transfusion is only a surrogate marker for anemia ‘Patel RM, Knezevic A, Shenvi N, et al. Association of Red Blood Cell Transfusion, Anemia, and Necrotizing Enterocolitis in Very Low-Birth-Weight Infants. JAMA 2016; 315:889
  • 17. Medications • Hyperosmolar medications and formulas can cause mucosal injury and may result in NEC- oral theophylline, multivitamins, or phenobarbitone. • Cimetidine, ranitidine, and famotidine, are associated with higher rates of NEC. • Antibiotic administration greater than five days duration is associated with an increased risk of NEC or death
  • 18. Clinical Presentation: • Majority of premature infants who develop NEC are healthy, feeding well, and growing babies. • Onset of symptoms varies and is inversely related to gestational age GA< 26 weeks-23 days, GA >31 weeks- 11 days. • Indian data peak age –end of 1stwk to 2nd week
  • 19. Systemic Signs • Apnea,Bradycardia • Respiratory distress • Lethargy • Poor feeding • Temperature instability. • Hypotension • Bleeding diathesis with consumption coagulopathy. Abdominal Signs • Gastric retention • Abdominal Distension • Abdominal redness & tenderness • Vomiting. • Diarrhea. • Rectal bleeding (hematochezia) • Bilious drainage from enteral feeding tubes
  • 20. Modified Bells staging for NEC: • Bell staging criteria (Walsh & Kleigman) provide a uniform definition of NEC based upon the severity of systemic, intestinal, and radiographic findings. 1. Stage I/suspected NEC 2. Stage II/proven NEC 3. Stage III/advanced NEC
  • 22. Investigations: Abdomen X ray • Abnormal gas pattern with dilated loops of bowel -ileus, early stages of NEC. • Bowel wall edema • Pneumatosis intestinalis, the hallmark of NEC, appears as bubbles of gas in the small bowel wall, stages II and III NEC . • Gasless abdomen indicating ascites. • Pneumoperitoneum bowel perforation occurs , IIIB NEC. -"football" sign on a supine radiograph,large hypolucent area in the central abdomen with markings from the falciform ligament. • Sentinel loops, a loop of bowel that remains in fixed position, is suggestive of necrotic bowel and/or perforation in the absence of pneumatosis intestinalis. In EPT, treatment -clinical suspicion as confirmatory radiographic findings may not be present
  • 23.
  • 24. USG abdomen: • USG more sensitive method to detect intramural air and portal venous gas . • USG can detect intermittent gas bubbles in liver parenchyma and the portal venous system that are not detected by radiographs • Color Doppler USG more sensitive than abdominal radiography in detecting bowel necrosis and alterations in bowel wall perfusion
  • 25. Blood and serum studies: • WBC count <1500/cumm –poor prognostic factor • Thrombocytopenia, persistent metabolic acidosis, and severe refractory hyponatremia triad of signs and help to confirm the diagnosis. • Serial measurements of CRP - diagnosis and assessment of response to therapy of severe NEC. • Blood cultures are positive in ˜40% of cases Analysis of stool: • Grossly bloody stools may be an indication of NEC, routine testing of stool for occult blood has no value . • 60% of infants will have Hemoccult-positive stools at any given time during hospitalization without any evidence for NEC
  • 26. D/D’s 1. Sepsis with Ileus 2. Infectious enteritis 3. Spontaneous intestinal perforation of the newborn 4. Intestinal obstruction –enterocolitis in Hirschsprung disease, ileal atresia, volvulus, meconium ileus, and intussusception. 5. Anal fissures 6. Neonatal appendicitis 7. Cow's milk protein allergy
  • 27. Management: • Medical management -Supportive care -Antibiotics -Radilogical and lab monitoring • Surgical management -Primary peritonael drainage -Laprotomy
  • 28. Supportive Care: • Bowel rest with gastrointestinal decompression with intermittent nasogastric suction. • Total parenteral nutrition • Fluid replacement to correct third space losses • Support of both the cardiovascular( inotropes) and respiratory systems (O2 & Ventilation as needed). • Correction of hematologic (DIC) and metabolic abnormalities (metabolic acidosis).
  • 29. Antibiotics: • After obtaining appropriate specimens for culture, broad spectrum antibiotic treatment should be initiated for suspected or proven NEC. • Regimens should provide coverage for pathogens that cause late-onset bacteremia. • Anaerobic coverage considered-peritonitis or pneumoperitoneum, suggesting intestinal perforation.
  • 30. • Lack of consensus, and the choice of antibiotic regimen varies among NICU 1. Ampicillin, gentamicin ,and metronidazole 2. Ampicillin, gentamicin, and clindamycin 3. Ampicillin, cefotaxime, and metronidazole 4. Piperacillin.tazobactam and gentamicin 5. Vancomycin, piperacillin-tazobactam, and gentamicin. 6. Meropenem
  • 31. Surgical management: Indications • Perforation on abdominal X ray(pneumoperitoneum) • Positvie test on paracentesis(stool ,organism) • Failure of medical management. • Single fixed bowel loop on radiograph • Abdominal wall erythema. • Palpable mass
  • 32. • Ideally surgery performed after intestinal necrosis but before perfoartion and peritonitis develop. • Surgical procedures- exploratory laparotomy with resection of the affected intestinal region, or primary peritoneal drainage (PPD). • PPD may be the preferred initial surgical procedure in extremely low birth weight (ELBW) infants and unstable premature infants.
  • 33. Complications: Early: • Infectious complications – Sepsis, meningitis, peritonitis, and abscess formation • Disseminated intravascular coagulation- intestinal or extraintestinal bleeding • Respiratory and cardiovascular complications – Hypotension, shock, and respiratory failure • Metabolic complications – Hypoglycemia and metabolic acidosis Late: • Stricture formation(9-36%) • Short bowel syndrome.(9% surgical operated cases)
  • 34. Mortality: 71,808 premature infants who were born between January 2005 and December 2006 -Vermont Oxford Network Fitzgibbons SC, Ching Y, Yu D, et al. Mortality of necrotizing enterocolitis expressed by birth weight categories. J Pediatr Surg 2009; 44:1072  BW 501 to 750 g – 42 %  BW 751 to 1000 g – 29 %  BW 1001 to 1250 g – 21 %  BW 1251 to 1500 g – 16 % • Mortality rate is higher in infants with more severe disease requiring surgical intervention(30.8 versus 6.8 percent). • Radiographic evidence of portal venous air, an increase in feeding volume that was greater than 20 mL/kg per day, and an increase in the concentration of HMF within 48 hours of developing NEC . • Hematocrit < 22 % ,I:T ratio > 0.5, and total lymphocyte count below 4000/microlt
  • 35. Long term outcome: • Approximately one-half of survivors have no long-term sequel. • 10% infants will have late gastrointestinal morbidity- persistent loose stools or frequent bowel movements • Infants with NEC were at increased risk for cerebral palsy, and cognitive and severe visual impairment. • Patients who were surgically treated had poorer neurodevelopmental outcome than those treated medically. • ELBW infants who required surgical care were more likely to have significant growth delay and poorer developmental outcome at 18 to 22 months. Hintz SR, Kendrick DE, Stoll BJ, et al. Neurodevelopmental and growth outcomes of extremely low birth weight infants after necrotizing enterocolitis. Pediatrics 2005; 115:696.
  • 36. Prevention of NEC: • Antenatal corticosteroids reduced the risk for NEC approximately by half. • Human milk compared with formula is the most important strategy associated with a lower risk of NEC( 2.8 times risk in formula fed) • TIMING AND ADVANCEMENT OF FEEDING  The optimal timing of initiation of minimal enteral (trophic) feeding remains uncertain and its association with NEC is lacking.  Advancement of enteral feed volumes at daily increments of 30 to 40 mL/kg compared to lower volumes of 15 to 24 mL/kg did not increase the risk of NEC or death in VLBW infants (BW <1500 g) Morgan J, Young L, McGuire W. Slow advancement of enteral feed volumes to prevent necrotising enterocolitis in very low birth weight infants. Cochrane Database Syst Rev 2015; :CD001241
  • 37. Prevention of NEC: • Routine use of probiotic –not recomended, the lack of an established regimen of optimal strain and dosing, and the absence of quality control regulation to ensure consistency and safety of product. • Oral immunoglobulins may reduce NEC by inhibiting the release of proinflammatory cytokines ,meta analysis administration of oral IgG or IgG/IgA combination did not reduce the incidence . • Lactoferrin,Arginine,Glutamine ,HMO-proven to be beneficaial in some studies but not routinely recommended.
  • 38. Prevention of NEC: • Avoidance of histamine 2 blockers:Immunity provided by gastric acid may be important in preventing the cascade of infectious and inflammatory events. • Avoidance of prolonged empirical antibiotic use :use of prolonged initial empiric antibiotic (≥5 days duration) started in the first three days of life was associated with an increased risk of NEC or death. • Unproven as measures to prevent NEC:use of feeding protocols, judicious advancement of feeding, avoidance of hypertonic formulas and contrast agents, and prompt treatment of polycythemia.